Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2021

01-10-2021 | Type 2 Diabetes | EDITORIAL

Which Comes First: Increased Intestinal Paracellular Permeability or Subepithelial Inflammation?

Author: Yasutada Akiba

Published in: Digestive Diseases and Sciences | Issue 10/2021

Login to get access

Excerpt

The intestinal barrier is the sum of multiple mechanisms, including those that regulate transepithelial electrical resistance, the transepithelial movement of small molecules, macromolecules, and particles, mucus secretion, and the bidirectional transport of water and ions. A key component of the intestinal barrier is paracellular permeability to solutes that traverse intercellular tight junctions [1]. Increased intestinal paracellular permeability is linked to the metabolic syndrome, obesity, diabetes, and fatty liver, in which chronic low-grade inflammation of adipose tissue, the pancreatic islets, and the liver is associated with measurable elevations of circulating lipopolysaccharides (LPS), termed metabolic endotoxemia, associated with enhanced LPS entry from the intestinal lumen into the circulation possibly via increased intestinal paracellular permeability [2]. Intestinal paracellular permeability is primarily regulated by intrinsic tight junction (TJ) proteins, including zonula occludens-1 (ZO-1), the occludins, and the claudins [3]. Changes in the expression of TJ proteins and their structure are well studied and correlate with paracellular permeability to molecular size markers such as FITC-dextran, polyethylene glycol, and carbohydrates and polyols such as mannitol and lactulose [4]. Although there is an extensive literature documenting associations among TJ protein abundance and structure, epithelial barrier function, and numerous disease states, a cause-and-effect relationship among these factors and the time course of barrier dysfunction changes have not been fully evaluated. Furthermore, there is often confusion regarding the contributions of individual intestinal segments toward the regulation of overall gut permeability. For instance, it is not known which specific intestinal segment is responsible for the paracellular absorption of macromolecular solutes, and if paracellular permeability changes precede or follow the development of metabolic syndrome. High-fat diet-induced elevation in circulating lipopolysaccharides (LPS) levels are explained by increased paracellular permeability, but in which intestinal segment? Although the density of Gram-negative microbes and thus LPS concentrations in the cecum or colon can be a millionfold or more greater than in the jejunum, it appears that in some instances such as in coprophagic rodents, the proximal small intestinal lumen also has high luminal LPS levels [5], suggesting that segmental differences should be examined in order to determine the segments responsible for absorption of specific substances. …
Literature
1.
go back to reference Hollander D, Kaunitz JD. The “Leaky Gut”: Tight junctions but loose associations? Dig Dis Sci. 2020;65:1277–1287.CrossRef Hollander D, Kaunitz JD. The “Leaky Gut”: Tight junctions but loose associations? Dig Dis Sci. 2020;65:1277–1287.CrossRef
2.
go back to reference Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–1481.CrossRef Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–1481.CrossRef
3.
go back to reference Weber CR. Dynamic properties of the tight junction barrier. Ann N Y Acad Sci. 2012;1257:77–84.CrossRef Weber CR. Dynamic properties of the tight junction barrier. Ann N Y Acad Sci. 2012;1257:77–84.CrossRef
4.
go back to reference Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516–1526.CrossRef Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516–1526.CrossRef
5.
go back to reference Akiba Y, Maruta K, Takajo T, et al. Lipopolysaccharides transport during fat absorption in rodent small intestine. Am J Physiol Gastrointest Liver Physiol. 2020;318:G1070–G1087.CrossRef Akiba Y, Maruta K, Takajo T, et al. Lipopolysaccharides transport during fat absorption in rodent small intestine. Am J Physiol Gastrointest Liver Physiol. 2020;318:G1070–G1087.CrossRef
6.
go back to reference Maruta K, Takajo T, Akiba Y, et al. GLP-2 acutely prevents endotoxin-related increased intestinal paracellular permeability in rats. Dig Dis Sci. 2020;65:2605–2618.CrossRef Maruta K, Takajo T, Akiba Y, et al. GLP-2 acutely prevents endotoxin-related increased intestinal paracellular permeability in rats. Dig Dis Sci. 2020;65:2605–2618.CrossRef
7.
go back to reference Nascimento JC, Matheus VA, Oliveira RB, Tada SFS, Collares-Buzato CB. High-fat diet induces disruption of the tight junction-mediated paracellular barrier in the proximal small intestine before the onset of type 2 diabetes and endotoxemia. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-020-06664-x. Nascimento JC, Matheus VA, Oliveira RB, Tada SFS, Collares-Buzato CB. High-fat diet induces disruption of the tight junction-mediated paracellular barrier in the proximal small intestine before the onset of type 2 diabetes and endotoxemia. Dig Dis Sci. (Epub ahead of print). https://​doi.​org/​10.​1007/​s10620-020-06664-x.
8.
go back to reference de Oliveira RB, Matheus VA, Canuto LP, De Sant’ana A, Collares-Buzato CB. Time-dependent alteration to the tight junction structure of distal intestinal epithelia in type 2 prediabetic mice. Life Sci. 2019;238:116971.CrossRef de Oliveira RB, Matheus VA, Canuto LP, De Sant’ana A, Collares-Buzato CB. Time-dependent alteration to the tight junction structure of distal intestinal epithelia in type 2 prediabetic mice. Life Sci. 2019;238:116971.CrossRef
9.
go back to reference David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563.CrossRef David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563.CrossRef
Metadata
Title
Which Comes First: Increased Intestinal Paracellular Permeability or Subepithelial Inflammation?
Author
Yasutada Akiba
Publication date
01-10-2021
Publisher
Springer US
Keyword
Type 2 Diabetes
Published in
Digestive Diseases and Sciences / Issue 10/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06724-2

Other articles of this Issue 10/2021

Digestive Diseases and Sciences 10/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.